Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Association of serum homocysteine, folate, and vitamin B₁₂ levels with cognitive function in levodopa-naïve patients with Parkinson's disease and mild cognitive impairment.

Created on 07 Jul 2026

Authors

Bo Jiang, Yue-Qi Guo

Published in

Neurologia i neurochirurgia polska. Jul 07, 2026. Epub Jul 07, 2026.

Abstract

The aim of this study was to examine changes in serum concentrations of total homocysteine (tHcy), folate, and vitamin B₁₂ (vit B₁₂) in levodopa-naïve patients with Parkinson's disease and mild cognitive impairment (PD-MCI) and to evaluate their association with cognitive function.
A retrospective analysis was conducted in 192 levodopa-naïve patients with early idiopathic Parkinson's disease (PD). On the basis of Montreal Cognitive Assessment (MoCA) scores, participants were classified into a PD-MCI group (n = 89) and a Parkinson's disease with normal cognitive function (PD-NCI) group (n = 103). In addition, 89 healthy individuals who underwent physical examination during the same period were included as a control group. Serum levels of tHcy, folate, and vit B₁₂, as well as cognitive function scores, were compared among the three groups.
Compared with the PD-NCI group, patients in the PD-MCI group demonstrated significantly lower scores in visuospatial and executive function, attention and calculation, abstraction, and delayed recall (p < 0.05). Serum tHcy levels were significantly higher in the PD-MCI group than in both the PD-NCI and control groups, whereas folate and vit B₁₂ levels were significantly reduced (p < 0.01). Among patients with PD, MoCA scores in the high tHcy subgroup were lower than those in the normal tHcy subgroup. Partial correlation analysis demonstrated that MoCA scores were negatively correlated with tHcy levels and positively correlated with folate and vit B₁₂ levels in patients with PD-MCI.
These findings suggest an association between elevated serum tHcy, reduced folate/vit B₁₂ levels, and cognitive impairment in PD-MCI. Folate and vit B₁₂ supplementation warrants further investigation in longitudinal or interventional studies.

PMID:
42411114
Bibliographic data and abstract were imported from PubMed on 07 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement